These cytokines comprise the inflammatory effectors of TREM-1 responsible for the pathological effects of TREM-1 signaling described in septic shock, rheumatoid arthritis, atherosclerosis, myocardial infarction, inflammatory bowel disease and retinal neovascular disorders (43, 69). This evidence concerns the gene TREM1 and inflammatory bowel disease.